Infinimax Platinum
Natural health product licensed in Canada
- Licence holder
- After Dark Labs, LLC
- NPN or DIN-HM
- 80073501
- Status
- Inactive licence
- Licence date
- 3 November 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Niacine | 3.75 mg | Not calculated |
| Zinc Source : Gluconate de zinc | 3.75 mg | 15,000 µg |
| L-arginine Source : Monohydrochlorure de L-arginine | 250 mg | Not calculated |
| Epimedium sagittatum Source : Feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 50 mg Potency : 10 % Icariin | 5 mg | Not calculated |
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 100 mg Potency : 45 % Steroidal Saponins | 5 mg | Not calculated |
| Malate de citrulline Source : Malate de citrulline | 25 mg | Not calculated |
| Reynoutria japonica Source : Racine Extract : Matériel brut sec Extraction ratio : 60:1 Dry plant equivalent : 600 mg Potency : 50 % Resveratrol | 10 mg | Not calculated |
| Beta vulgaris Source : Racine Extract : Matériel brut sec Extraction ratio : 1:1 Dry plant equivalent : 130 mg Potency : 2.45 % Nitrate | 130 mg | Not calculated |
| Eurycoma longifolia Source : Racine Extract : Matériel brut sec Extraction ratio : 100:1 Dry plant equivalent : 5,000 mg Potency : 22 % Eurypeptides | 50 mg | Not calculated |
| Eurycoma longifolia Source : Racine Potency : 40 % Glycosaponins | Not specified | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 mg | 5 mg | Not calculated |
| Erythroxylum catuaba Source : Écorce âgée | 130 mg | Not calculated |
| Ptychopetalum olacoides Source : Écorce âgée Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 mg | 5 mg | Not calculated |
| Serenoa repens Source : Fruit | 5 mg | Not calculated |
| Cucurbita pepo Source : Graine(s) | 5 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 mg | 5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Eurycoma longifolia helps promote testosterone production. Eurycoma longifolia support testosterone production. Niacin helps in normal growth and development. Niacin and zinc help in energy metabolism and tissue formation. Niacin and zinc help to maintain the body's ability to metabolize nutrients. Zinc helps in connective tissue formation; to maintain healthy skin, bones, hair, nails, and immune function. L-Arginine is a non-essential amino acid that is involved in protein synthesis. Maca provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea). Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
- Précautions et mises en garde
Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease, a hormone sensitive condition (e.g. prostate cancer), hypertension, cardiac disease, or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, blood thinners, steroidal drug therapy, CNS-acting medications, or any prescription medications as resveratrol may alter the effectiveness of these medications. People sensitive to nicotinic acid may experience flushing of the skin that is generally mild and transient.
Source
Official Health Canada record, licence 80073501
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.